先声药业集团有限公司（股票代码：02096）于2026年5月20日在香港联交所发布翌日披露报表，披露公司当日回购股份的最新进展。
当日，公司于香港联交所场内回购2,067,000股普通股，占当日已发行股本约0.0796%。回购价格区间介乎每股港币10.3623元至10.69元，合计动用资金约港币21,738,432.30（即约2,173.84万港元）。回购完成后，公司已发行股本仍为2,595,697,618股，库藏股数量保持为零。
公告显示，此次回购依据2025年6月13日通过的购回授权进行，授权总额为247,469,761股。截至目前，公司已累计回购26,194,000股，占该授权通过时已发行股份总数的约1.0585%。
公司在公告中确认，此次回购过程已遵守香港联交所主板上市规则及相关法律法规，经董事会正式批准并履行了所有必要审批手续。上述公告由执行董事及联席公司秘书万玉山签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.